Drug and pharmaceutical recalls

Asteria Health is recalling a testosterone and triamcinolone acetonide combination pellet due to the potential presence of metal particulate matter in the product. The recall affects lot #256000104 with an expiration date of 07/30/2026, distributed nationwide. No injuries have been reported.

Asteria Health is recalling specific lots of testosterone 75mg/anastrozole 4mg sterile pellets due to potential metal particulate matter found in the product. The affected lots were distributed nationwide. No injuries have been reported.

Asteria Health is recalling one lot of testosterone 100mg/anastrozole 4mg pellets because they may contain metal particles. The affected lot (254000104, expiring 05/27/2026) was distributed nationwide. No injuries have been reported.

Asteria Health testosterone pellets (303 mg) may contain metal particulate matter that could contaminate the product. The recall affects 1,015 pellets from lot #251000124 with an expiration date of 06/02/2026 distributed nationwide. No injuries have been reported.

Asteria Health testosterone pellets (200 mg) may contain metal particulate matter due to a manufacturing issue. The FDA has classified this as a Class II recall affecting multiple lot numbers distributed nationwide. No injuries have been reported to date.

Asteria Health is recalling certain testosterone pellet injections because they may contain metal particulate matter. The contamination was identified in seven specific manufacturing lots with expiration dates between June 2026 and September 2026. No injuries have been reported so far.

Asteria Health is recalling testosterone pellets (87.5 mg) because they may contain metal particles. The recall affects three specific lots distributed nationwide. No injuries have been reported so far.

Asteria Health testosterone pellets (62.5 mg) may contain metal particulate matter. The affected lot (251000125, expiring 06/02/2026) was distributed nationwide. About 1,758 pellets are involved in this recall.

Asteria Health testosterone pellets may contain metal particulate matter as a result of a manufacturing issue. The recall affects specific lot numbers distributed nationwide. No injuries have been reported to date.

Asteria Health's testosterone pellets may contain metal particulate matter due to a manufacturing issue. The FDA has identified five affected lot numbers distributed nationwide. No injuries have been reported.

Asteria Health testosterone pellets (25 mg) may contain metal particulate matter due to a manufacturing issue. The FDA has classified this as a Class II recall affecting multiple lot numbers distributed nationwide. No injuries have been reported to date.

Asteria Health is recalling testosterone pellets (18.0 mg, lot #251000126, expiring 06/03/2026) because they may contain metal particulate matter. The recall affects 146 pellets distributed nationwide. No injuries have been reported.

Asteria Health testosterone pellets (12.5 mg) may contain metal particulate matter due to a manufacturing issue. The recall affects specific lots distributed nationwide. No injuries have been reported to date.

Asteria Health's estradiol 37.5 mg sterile pellets may contain metal particulate matter. This affects lot 253000125, expiring 06/09/2026. No injuries have been reported to date.

Asteria Health estradiol 25 mg pellets may contain metal particulate matter. The affected lot (253000136, expiring 07/01/2026) was distributed nationwide. No injuries have been reported.

Asteria Health is recalling estradiol 22 mg pellets (Lot# 253000126, expiring 06/09/2026) because they may contain metal particulate matter. The recall affects 133 pellets distributed nationwide. No injuries have been reported.

Asteria Health's estradiol 20 mg hormone pellets may contain metal particulate matter. This affects one specific lot (253000124) with an expiration date of June 2, 2026, distributed nationwide. No injuries have been reported.

Asteria Health is recalling estradiol pellets (18 mg) because some may contain metal particulate matter. The affected lot was distributed nationwide. No injuries have been reported.

Asteria Health estradiol 15 mg pellets may contain metal particulate matter, a foreign substance that could pose a health risk. The FDA has identified four affected lot numbers distributed nationwide. No injuries have been reported to date.

Asteria Health estradiol pellets (12.5 mg) may contain metal particulate matter. The affected lots were distributed nationwide. No injuries have been reported to date.

Asteria Health is recalling estradiol hormone pellets (10 mg) because they may contain metal particles. The affected pellets were distributed nationwide. No injuries have been reported so far.

Presence of Foreign substance - potential presence of metal particulate matter

Unichem Pharmaceuticals distributed 60,000 tablets of Doxazosin 4 mg with incorrect imprinting on the tablets themselves. This labeling error could cause confusion about the medication's identity and strength. The affected lot is GDSH25006, which expires in August 2027.

Pro Numb Tattoo Numbing Spray (4% Lidocaine) in lot J15 was distributed nationwide but did not meet FDA manufacturing standards. The spray may not be safe or effective as a result.

Pro Numb Tattoo Numbing Spray (5% lidocaine) is being recalled due to manufacturing quality control issues. The FDA found that the product was not made under proper conditions. Certain lot numbers (J01–J14 and J55–J69) distributed nationwide may be affected.

Sun Pharmaceutical is recalling one lot of Diclofenac Sodium Topical Gel, 3% (Lot #AD92721, expiring 3/31/2027) because the gel's thickness is slightly lower than required specifications. The product was distributed nationwide and is sold by prescription only.

Rheumacare capsules manufactured by Virgo UAP Pharma in India were found to contain lead due to manufacturing defects. The affected product is a 30-count bottle with lot numbers CAM040 (expires 06/30/2029) or CAL079-N (expires 09/30/2028). Only 4 bottles were distributed to a customer in New York.

Granules Pharmaceuticals is recalling certain bottles of trazodone 50 mg because some bottles may contain foreign tablets or capsules mixed in. This affects 71,424 bottles with batch number 6160008A and an expiration date of 12/31/2026. No injuries have been reported.

Green Lumber Natural Fuel For Men capsules were sold as a supplement but contain tadalafil, a prescription medication approved only for treating erectile dysfunction and certain heart conditions. The product was marketed and sold without FDA approval and without listing tadalafil on the label. Tadalafil can cause serious side effects, especially in people taking certain other medications or with certain health conditions.

Unichem Pharmaceuticals is recalling one lot of bisoprolol fumarate and hydrochlorothiazide tablets (2.5 mg/6.25 mg) because they contain higher-than-allowed levels of N-Nitroso Bisoprolol, a potentially harmful impurity. The affected lot was manufactured in India and distributed nationwide.